SVB Wealth LLC Makes New $345,000 Investment in Henry Schein, Inc. (NASDAQ:HSIC)

SVB Wealth LLC purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 4,992 shares of the company’s stock, valued at approximately $345,000.

Several other institutional investors have also modified their holdings of HSIC. CIBC Asset Management Inc increased its stake in Henry Schein by 1.0% in the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock valued at $1,235,000 after purchasing an additional 169 shares in the last quarter. Studio Investment Management LLC grew its holdings in Henry Schein by 3.8% in the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after purchasing an additional 172 shares during the last quarter. Central Pacific Bank Trust Division increased its position in shares of Henry Schein by 2.0% in the fourth quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock valued at $706,000 after buying an additional 200 shares in the last quarter. Sanctuary Advisors LLC raised its stake in shares of Henry Schein by 5.0% during the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company’s stock worth $294,000 after buying an additional 203 shares during the last quarter. Finally, Huntington National Bank boosted its position in shares of Henry Schein by 16.8% in the 3rd quarter. Huntington National Bank now owns 1,515 shares of the company’s stock worth $110,000 after buying an additional 218 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Down 0.7 %

Shares of NASDAQ:HSIC opened at $70.31 on Wednesday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.73 billion, a price-to-earnings ratio of 28.93, a PEG ratio of 2.13 and a beta of 0.91. The stock’s 50-day moving average price is $74.41 and its two-hundred day moving average price is $72.51. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSICGet Free Report) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.66 earnings per share. On average, research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. Jefferies Financial Group raised their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. UBS Group dropped their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Finally, Wells Fargo & Company assumed coverage on Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective on the stock. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $81.10.

Read Our Latest Stock Analysis on Henry Schein

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.